- 专利标题： BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
-
申请号： US18159798申请日： 2023-01-26
-
公开(公告)号： US20230338389A1公开(公告)日： 2023-10-26
- 发明人: Oleg Vechorkin , Minh Nguyen , Chao Qi , Anlai Wang , Michael Witten , Yao Xu , Hai Fen Ye , Ke Zhang , Peng Zhao , Wenqing Yao
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61P35/00 ; A61K31/437 ; A61K31/496 ; A61K31/4995 ; C07D471/04 ; C07D519/00
摘要：
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR enzyme and are useful in the treatment of FGFR-associated diseases such as cancer.
公开/授权文献
- US12083124B2 Bicyclic heterocycles as FGFR inhibitors 公开/授权日：2024-09-10
信息查询
IPC分类:
